1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Venezuela Pharmaceuticals and Healthcare Report Q2 2016

Venezuela Pharmaceuticals and Healthcare Report Q2 2016

  • April 2016
  • -
  • Business Monitor International
  • -
  • 103 pages

Includes 3 FREE quarterly updates

Headline Expenditure Projections

- Pharmaceuticals: VEB88.7bn (USD3.0bn) in 2015 to VEB259.6bn (USD1.3bn) in 2016; +192.6% inlocal currency terms and -57.2% in US dollar terms. Forecast has been revised upward from Q116 inlocal currency terms due to updated macroeconomic considerations.

- Healthcare: VEB246.5bn (USD8.4bn) in 2015 to VEB815.8bn (USD12.5bn) in 2016; +231% in localcurrency terms and +47.9% in US dollar terms. Forecast has been revised upward from Q116 due toupdated macroeconomic considerations.

Table Of Contents

Venezuela Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Venezuela 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Venezuela 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Venezuela 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Venezuela 2012-2020) 17
Prescription Drug 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Venezuela 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Venezuela 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Venezuela 2012-2020) 23
OTC Medicine Market Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Venezuela 2012-2020) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Venezuela 2014-2020) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Venezuela 2014-2020) 30
Industry Risk/Reward Index 31
Americas Risk/Reward Index 31
Venezuela Risk/Reward Index 37
Rewards 37
Risks 37
Regulatory Review 39
Intellectual Property Issues 39
Pricing Regime 43
Reimbursement Regime 45
Market Overview 47
Healthcare Sector 47
Table: Healthcare Resources (Venezuela 2010-2015) 50
Table: Healthcare Personnel (Venezuela 2010-2015) 50
Table: Healthcare Activity (Venezuela 2010-2015) 51
Research and Development 53
Clinical Trials 54
Epidemiology 55
Competitive Landscape 58
Research-Based Industry 58
Generic Drugmakers 60
Pharmaceutical Distribution 61
Pharmaceutical Retail Sector 63
Company Profile 65
Boehringer Ingelheim 65
Calox International 67
Elmor 69
GlaxoSmithKline 72
Grupo Farma 75
Merck and Co 78
Novartis 81
Pfizer 84
Sanofi 88
Strides Latina (Sumifarma) 90
Demographic Forecast 92
Demographic Outlook 2015 92
Table: Population Headline Indicators (Venezuela 1990-2025) 93
Table: Key Population Ratios (Venezuela 1990-2025) 93
Table: Urban/Rural Population and Life Expectancy (Venezuela 1990-2025) 94
Table: Population By Age Group (Venezuela 1990-2025) 94
Table: Population By Age Group % (Venezuela 1990-2025) 95
Glossary 97
Methodology 99
Pharmaceutical Expenditure Forecast Model 99
Healthcare Expenditure Forecast Model 99
Notes On Methodology 100
Risk/Reward Index Methodology 101
Index Overview 102
Table: Pharmaceutical Risk/Reward Index Indicators 102
Indicator Weightings 103

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.